Bibliographie (2530)
Will the pandemic fade into an ordinary disease like the flu? The world is watching Denmark for clues.
lundi, 04 octobre 2021 04:38 Écrit par Zouhair SouissiWill the pandemic fade into an ordinary disease like the flu? The world is watching Denmark for clues – Science
The post Will the pandemic fade into an ordinary disease like the flu? The world is watching Denmark for clues. appeared first on Links Medicus.
Editorial | Covid-19 vaccination: evidence of waning immunity is overstated.
lundi, 04 octobre 2021 04:38 Écrit par Zouhair SouissiCovid-19 vaccination: evidence of waning immunity is overstated – The BMJ Related: COVID vaccine immunity is waning — how much does that matter? – “As debates about booster shots heat up, what’s known about the duration of vaccine-based immunity is still evolving”. COVID vaccine effects wane over time but still prevent death and severe illness. […]
The post Editorial | Covid-19 vaccination: evidence of waning immunity is overstated. appeared first on Links Medicus.
Systematic Review: Does testing for cancer in people with unprovoked blood clots in the legs and lungs reduce cancer- and blood clot-related death and illness?
lundi, 04 octobre 2021 04:38 Écrit par Zouhair SouissiSummary: Does testing for cancer in people with unprovoked blood clots in the legs and lungs reduce cancer- and blood clot-related death and illness? – Cochrane Library Original article: Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE – Cochrane Library
The post Systematic Review: Does testing for cancer in people with unprovoked blood clots in the legs and lungs reduce cancer- and blood clot-related death and illness? appeared first on Links Medicus.
![[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.](/media/k2/items/cache/f41687065406fae6d8ff38f5ee43f226_M.jpg)
[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.
lundi, 04 octobre 2021 04:38 Écrit par Zouhair SouissiMerck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study Commentaries: Expert reaction to interim analysis of oral antiviral molnupiravir – Science Media Centre Merck’s antiviral pill reduces hospitalization […]
The post [Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19. appeared first on Links Medicus.
Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
lundi, 04 octobre 2021 04:38 Écrit par Zouhair SouissiVaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance – The BMJ Original Guidance: NICE COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis. Related: Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. Review: Clinical characteristics and pharmacological management of COVID-19 vaccine–induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis. Vaccine-induced immune thrombotic thrombocytopenia: what […]
The post Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance. appeared first on Links Medicus.
Another meta-analysis suggests standard-dose prophylactic anticoagulation is the best option for patients hospitalized with Covid-19.
vendredi, 01 octobre 2021 13:42 Écrit par Zouhair SouissiA Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients – Frontiers in Pharmacology Related: M-A: Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19 – According to this analysis, standard-dose prophylactic anticoagulation should be the […]
The post Another meta-analysis suggests standard-dose prophylactic anticoagulation is the best option for patients hospitalized with Covid-19. appeared first on Links Medicus.
Transition to endemicity: Understanding COVID-19.
vendredi, 01 octobre 2021 13:42 Écrit par Zouhair SouissiTransition to endemicity: Understanding COVID-19 – Cell Related: COVID will likely shift from pandemic to endemic — but what does that mean? Perspective | How Endemic COVID Becomes a Manageable Risk – “Businesses and schools must adapt, because the dual threat from the coronavirus and the flu will be too severe”.
The post Transition to endemicity: Understanding COVID-19. appeared first on Links Medicus.
Review: COVID-19 in older adults.
vendredi, 01 octobre 2021 13:42 Écrit par Zouhair SouissiCOVID-19 in older adults – Cleveland Clinic Journal of Medicine
The post Review: COVID-19 in older adults. appeared first on Links Medicus.
International registry shows mortality after ECMO for patients with COVID-19 worsened during 2020.
vendredi, 01 octobre 2021 13:42 Écrit par Zouhair SouissiExtracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry – The Lancet Commentaries: ECMO in COVID-19: do not blame the tool – The Lancet ECMO life support offers sickest COVID-19 patients a chance to survive, but a slimmer one than once thought – Michigan Medicine – University of Michigan […]
The post International registry shows mortality after ECMO for patients with COVID-19 worsened during 2020. appeared first on Links Medicus.
Over a third of COVID-19 patients diagnosed with at least one long-COVID symptom.
jeudi, 30 septembre 2021 12:51 Écrit par Zouhair SouissiNews release: Over a third of COVID-19 patients diagnosed with at least one long-COVID symptom – University of Oxford Original study: Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 – PLOS Medicine Commentaries: Two studies tie long COVID-19 to severe initial illness – CIDRAP Covid: 37% […]
The post Over a third of COVID-19 patients diagnosed with at least one long-COVID symptom. appeared first on Links Medicus.
![[Press release – Not published yet] Clover’s COVID-19 vaccine candidate demonstrates 79% efficacy against Delta.](/media/k2/items/cache/2f7c13232e13404e23cfd28dd9d8bff9_XS.jpg)
